Utah Medical Products ROE 2006-2018 | UTMD

Current and historical return on equity (ROE) values for Utah Medical Products (UTMD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Utah Medical Products ROE for the three months ending December 31, 2018 was 18.03%.
Utah Medical Products ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-12-31 $0.02B $0.09B 20.93%
2018-09-30 $0.01B $0.09B 14.41%
2018-06-30 $0.01B $0.08B 11.08%
2018-03-31 $0.01B $0.08B 11.29%
2017-12-31 $0.01B $0.08B 11.65%
2017-09-30 $0.02B $0.08B 20.00%
2017-06-30 $0.01B $0.08B 19.18%
2017-03-31 $0.01B $0.07B 18.18%
2016-12-31 $0.01B $0.07B 16.84%
2016-09-30 $0.01B $0.07B 16.78%
2016-06-30 $0.01B $0.07B 17.08%
2016-03-31 $0.01B $0.07B 17.27%
2015-12-31 $0.01B $0.07B 17.78%
2015-09-30 $0.01B $0.07B 18.11%
2015-06-30 $0.01B $0.07B 18.39%
2015-03-31 $0.01B $0.06B 18.60%
2014-12-31 $0.01B $0.07B 18.68%
2014-09-30 $0.01B $0.06B 18.97%
2014-06-30 $0.01B $0.07B 19.51%
2014-03-31 $0.01B $0.06B 20.51%
2013-12-31 $0.01B $0.06B 21.62%
2013-09-30 $0.01B $0.06B 20.75%
2013-06-30 $0.01B $0.05B 21.57%
2013-03-31 $0.01B $0.05B 20.30%
2012-12-31 $0.01B $0.05B 20.94%
2012-09-30 $0.01B $0.05B 22.10%
2012-06-30 $0.01B $0.05B 20.93%
2012-03-31 $0.01B $0.05B 21.69%
2011-12-31 $0.01B $0.04B 17.61%
2011-09-30 $0.01B $0.04B 17.95%
2011-06-30 $0.01B $0.04B 17.95%
2011-03-31 $0.01B $0.04B 15.48%
2010-12-31 $0.01B $0.04B 17.95%
2010-09-30 $0.01B $0.04B 17.95%
2010-06-30 $0.01B $0.04B 18.30%
2010-03-31 $0.01B $0.04B 21.33%
2009-12-31 $0.01B $0.04B 21.92%
2009-09-30 $0.01B $0.04B 22.38%
2009-06-30 $0.01B $0.04B 21.92%
2009-03-31 $0.01B $0.04B 21.33%
2008-12-31 $0.01B $0.04B 20.78%
2008-09-30 $0.01B $0.04B 20.25%
2008-06-30 $0.01B $0.04B 20.51%
2008-03-31 $0.01B $0.04B 20.92%
2007-12-31 $0.01B $0.04B 21.19%
2007-09-30 $0.01B $0.04B 21.62%
2007-06-30 $0.01B $0.04B 22.07%
2007-03-31 $0.01B $0.04B 22.54%
2006-12-31 $0.01B $0.04B 23.02%
2006-09-30 $0.01B $0.04B 23.53%
2006-06-30 $0.01B $0.03B 23.70%
2006-03-31 $0.01B $0.03B 23.70%
2005-12-31 $0.01B $0.03B 23.36%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.321B $0.042B
Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $129.838B 25.32
Medtronic (MDT) Ireland $112.952B 16.51
Stryker (SYK) United States $67.256B 24.66
Boston Scientific (BSX) United States $48.820B 23.72
Baxter (BAX) United States $37.991B 24.37
Zimmer Biomet Holdings (ZBH) United States $24.550B 15.71
Smith & Nephew SNATS (SNN) United Kingdom $16.615B 0.00
Canopy Growth (CGC) Canada $14.912B 0.00
ResMed (RMD) United States $14.218B 26.96
Aurora Cannabis (ACB) Canada $9.118B 64.29
Bio-Rad Laboratories (BIO) United States $8.765B 50.28
Perrigo (PRGO) Ireland $6.633B 10.75
Hill-Rom Holdings (HRC) United States $6.374B 19.72
Insulet (PODD) United States $4.900B 1642.60
GW Pharmaceuticals (GWPH) United Kingdom $4.701B 0.00
ICU Medical (ICUI) United States $4.568B 28.29
Haemonetics (HAE) United States $4.189B 37.16
Hutchison China MediTech (HCM) China $4.046B 0.00
Agios Pharmaceuticals (AGIO) United States $3.268B 0.00
Neogen (NEOG) United States $2.958B 48.10
NuVasive (NUVA) United States $2.784B 24.18
Quidel (QDEL) United States $2.365B 21.17
National Vision Holdings (EYE) United States $2.220B 43.66
Aphria (APHA) $1.917B 0.00
HEXO (HEXO) $1.424B 0.00
Phibro Animal Health (PAHC) United States $1.349B 19.38
VAREX IMAGING (VREX) United States $1.222B 23.93
Cardiovascular Systems (CSII) United States $1.190B 854.00
AtriCure (ATRC) United States $1.049B 0.00
Lantheus Holdings (LNTH) United States $0.931B 25.16
Omeros (OMER) United States $0.908B 0.00
PetIQ (PETQ) United States $0.862B 24.67
MacroGenics (MGNX) United States $0.791B 0.00
Cerus (CERS) United States $0.787B 0.00
NanoString Technologies (NSTG) United States $0.737B 0.00
TG Therapeutics (TGTX) United States $0.689B 0.00
Evolus (EOLS) United States $0.681B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.666B 22.66
OraSure Technologies (OSUR) United States $0.594B 25.86
Surmodics (SRDX) United States $0.546B 79.43
LeMaitre Vascular (LMAT) United States $0.536B 25.46
Meridian Bioscience (VIVO) United States $0.531B 15.82
Quanterix (QTRX) United States $0.492B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.322B 0.00
Insys Therapeutics (INSY) United States $0.313B 0.00
BioLife Solutions (BLFS) United States $0.305B 125.85
Vapotherm (VAPO) United States $0.296B 0.00
Rockwell Medical (RMTI) United States $0.271B 0.00
Cytosorbents (CTSO) United States $0.219B 0.00
Owens & Minor (OMI) United States $0.213B 2.91
Zynex (ZYXI) United States $0.171B 18.31
Chimerix (CMRX) United States $0.133B 0.00
Bovie Medical (APYX) United States $0.131B 0.00
Fonar (FONR) United States $0.125B 6.68
Chembio Diagnostics (CEMI) United States $0.121B 0.00
Surface Oncology (SURF) United States $0.113B 0.00
InfuSystems Holdings (INFU) United States $0.090B 0.00
Female Health (VERU) United States $0.088B 0.00
United-Guardian (UG) United States $0.088B 20.06
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.071B 21.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Senestech (SNES) United States $0.034B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.025B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 13.71